MedTrace Logo

Evaluation of Left Ventricular Autothreshold, Phase Two

NCT01242722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-10-03

No results posted yet for this study

Summary

This study will collect data, from an implanted Cardiac Resynchronization Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart failure devices.

Conditions

Interventions

DEVICE

CRT-D

Cardiac pacing via a pulse generator and implanted intracardiac leads

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Kenneth L Ellenbogen, M.D. · Virginia Commonwealth University Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01242722 on ClinicalTrials.gov